ForumIAS LATEST
- 24 May |UPSC Prelims 2026 Paper Solved LIVE | GS Paper Detailed Discussion | ForumIAS Click Here →
- 17 May | ABC of Indian Sociology Series | 'H' = HAROLD COULD | Sociology Optional Simplified Click Here →
- 15 May | If You Are Giving Prelims 2026, Watch This Before Entering the Exam Hall Click Here to listen to Ayush Sir's advice →
News: ICMR, under the Department of Health Research, Ministry of Health and Family Welfare, successfully organized “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect.
About Medical Innovations Patent Mitra: I2I Connect

- It is India’s largest biomedical and technology transfer facilitation event held at the Manekshaw Centre, New Delhi.
- Organized by: It has been organized by Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of Health and Family Welfare.
- It has establishment of one of the country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative.
- Aim: It aims to bridge the gap between laboratory research and commercial healthcare products.
- It also aims to support India’s goal of becoming more self-reliant in healthcare technologies.
- Focus: It focuses on turning Indian medical research into practical healthcare solutions that can reach hospitals, laboratories, and patients faster.
- Highlights of the Event:
- The Indian Biomedical Patent Landscape Report and the Technology Compendium were launched during the event.
- A key highlight was the transfer of 41 public health technologies from Indian Council of Medical Research (ICMR) institutes and innovators to industry partners for further development, manufacturing, and commercialization.
- These technologies covered advanced diagnostics, vaccines, medical devices, and biomedical solutions aimed at addressing major public health challenges.
- Transferred technologies: The transferred technologies included glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, along with diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis, and Mpox.
- First, well-characterized biomaterials, including inactivated KFD and Chandipura viruses, were also handed over to industry partners, further strengthening India’s biomedical research and manufacturing ecosystem.
- The event also featured over 100 technologies in diagnostics, therapeutics, and medical devices developed by ICMR institutes, researchers, and startups, while enabling direct interaction between innovators and industry stakeholders.
About Medical Innovation Patent Mitra Initiative![]()
|





